Comorbidity screening/prevention score
| Comorbidity | Screening or prevention measure | Optimal timing | Points in the score | |
| CV disease screening (50 points) | Diabetes | Fasting blood glucose | Once per year | 15 |
| High blood pressure | Blood pressure measurement | Once per year | 15 | |
| Hyperlipidaemia | Lipid measurement | Once per year | 15 | |
| Renal insufficiency | Creatinine measurement | Once per year | 5 | |
| Cancer screening (20 points) | Colon/rectum | Faecal occult blood test or colonoscopy | If age>50 years: every 2 (test) to 5 (colonoscopy) years | 7 men and 5 women |
| Skin | Dermatologist clinical assessment | Once if immunosuppressants | 6 men and 5 women | |
| Prostate | Digital rectal examination or prostate-specific antigen dosage | If male gender and age>50 years: once | 7 men and 0 women | |
| Breast | Mammography | If female gender and age 50–75 years: every 2 years | 0 men and 5 women | |
| Cervix | Cervical smear | If female gender: every 3 years | 0 men and 5 women | |
| Infection prevention (20 points) | Influenza | Vaccination | Once per year | 10 |
| Pneumococcus | Vaccination | Every 5 years | 10 | |
| Osteoporosis (10 points) | Osteoporosis | Bone mineral density | Once in lifetime | 10 |
The score ranges 0–100, where optimal screening and prevention is a score of 0. Points in the score were given to patients not receiving the measure and points differed for cancer between women and men.
CV, cardiovascular.